EUVIMEDEUVIMED entdecken
Open Access

Chronic airway epithelial hypoxia exacerbates injury in muco-obstructive lung disease through mucus hyperconcentration

Yu Mikami iD, Barbara R Grubb iD, Troy D Rogers iD, Hong Dang iD, Takanori Asakura iD, Pradeep Kota, Rodney C Gilmore iD, Kenichi Okuda iD, Lisa C Morton iD, Ling Sun iD, Gang Chen iD, Jason A Wykoff iD und 10 weitere

Science Translational Medicine · 07.06.2023 · 15 (699)

DOI: 10.1126/scitranslmed.abo7728 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 07.06.2023. Verfasst von Yu Mikami und 21 weiteren Autor:innen. Beteiligte Einrichtung: Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. Hauptthemen laut MEDLINE: COVID-19, Pulmonary Disease, Chronic Obstructive, Cystic Fibrosis. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Unlike solid organs, human airway epithelia derive their oxygen from inspired air rather than the vasculature. Many pulmonary diseases are associated with intraluminal airway obstruction caused by aspirated foreign bodies, virus infection, tumors, or mucus plugs intrinsic to airway disease, including cystic fibrosis (CF). Consistent with requirements for luminal O 2 , airway epithelia surrounding mucus plugs in chronic obstructive pulmonary disease (COPD) lungs are hypoxic. Despite these observations, the effects of chronic hypoxia (CH) on airway epithelial host defense functions relevant to pulmonary disease have not been investigated. Molecular characterization of resected human lungs from individuals with a spectrum of muco-obstructive lung diseases (MOLDs) or COVID-19 identified molecular features of chronic hypoxia, including increased EGLN3 expression, in epithelia lining mucus-obstructed airways. In vitro experiments using cultured chronically hypoxic airway epithelia revealed conversion to a glycolytic metabolic state with maintenance of cellular architecture. Chronically hypoxic airway epithelia unexpectedly exhibited increased MUC5B mucin production and increased transepithelial Na + and fluid absorption mediated by HIF1α/HIF2α-dependent up-regulation of β and γENaC (epithelial Na + channel) subunit expression. The combination of increased Na + absorption and MUC5B production generated hyperconcentrated mucus predicted to perpetuate obstruction. Single-cell and bulk RNA sequencing analyses of chronically hypoxic cultured airway epithelia revealed transcriptional changes involved in airway wall remodeling, destruction, and angiogenesis. These results were confirmed by RNA–in situ hybridization studies of lungs from individuals with MOLD. Our data suggest that chronic airway epithelial hypoxia may be central to the pathogenesis of persistent mucus accumulation in MOLDs and associated airway wall damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Pulmonary Disease, Chronic ObstructiveCystic FibrosisHumansLungMucusHypoxia

Autor:innen und Institutionen

  • Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
  • Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Center for Environmental Health and Susceptibility, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

ORCID-Profile: Yu Mikami, Barbara R Grubb, Troy D Rogers, Hong Dang, Takanori Asakura, Rodney C Gilmore, Kenichi Okuda, Lisa C Morton, Ling Sun, Gang Chen, Jason A Wykoff, Camille Ehre, Catharina van Heusden, Alessandra Livraghi-Butrico, Martina Gentzsch, Brian Button, Scott H Randell, Wanda K O'Neal, Richard C Boucher

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Mikami, Y., Grubb, B. R., Rogers, T. D., Dang, H., Asakura, T., Kota, P., Gilmore, R. C., Okuda, K., Morton, L. C., Sun, L., Chen, G., Wykoff, J. A., Ehre, C., Vilar, J., van Heusden, C., Livraghi-Butrico, A., Gentzsch, M., Button, B., Stutts, M. J., …, & Boucher, R. C. (2023). Chronic airway epithelial hypoxia exacerbates injury in muco-obstructive lung disease through mucus hyperconcentration. Science Translational Medicine, 15(699). https://doi.org/10.1126/scitranslmed.abo7728

Vancouver

Mikami Y, Grubb BR, Rogers TD, Dang H, Asakura T, Kota P, et al. Chronic airway epithelial hypoxia exacerbates injury in muco-obstructive lung disease through mucus hyperconcentration. Science Translational Medicine. 2023;15(699). doi:10.1126/scitranslmed.abo7728

BibTeX
@article{Mikami2023,
  author = {Mikami, Yu and Grubb, Barbara R and Rogers, Troy D and Dang, Hong and Asakura, Takanori and Kota, Pradeep and Gilmore, Rodney C and Okuda, Kenichi and Morton, Lisa C and Sun, Ling and Chen, Gang and Wykoff, Jason A and Ehre, Camille and Vilar, Juan and van Heusden, Catharina and Livraghi-Butrico, Alessandra and Gentzsch, Martina and Button, Brian and Stutts, M Jackson and Randell, Scott H and O'Neal, Wanda K and Boucher, Richard C},
  title = {Chronic airway epithelial hypoxia exacerbates injury in muco-obstructive lung disease through mucus hyperconcentration},
  journal = {Science Translational Medicine},
  year = {2023},
  volume = {15},
  number = {699},
  doi = {10.1126/scitranslmed.abo7728}
}
Kostenlos starten →